Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,177Revenue (TTM) $M109Net Margin (%)-1.5Altman Z-Score4.4
Enterprise Value $M2,249EPS (TTM) $-0.1Operating Margin %40.3Piotroski F-Score5
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)7.3Higher ROA y-yN
Price/Book6.410-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales20.65-y EBITDA Growth Rate %--Current Ratio0.7Lower Leverage y-yY
Price/Free Cash Flow52.9y-y EBITDA Growth Rate %87.7ROA % (ttm)-0.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-0.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)2.0Gross Margin Increase y-yY

Gurus Latest Trades with LGND

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

LGND is held by these investors:



LGND: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HIGGINS JOHN LCEO 2017-03-20Sell4,000$109.1-4.61view
HIGGINS JOHN LCEO 2017-03-08Sell4,000$107.06-2.79view
FOEHR MATTHEW WPresident and COO 2017-03-02Sell6,879$103.390.66view
Aryeh JasonDirector 2017-02-28Sell32,000$106.35-2.14view
Aryeh JasonDirector 2016-11-25Sell18,479$107.31-3.02view
Aryeh JasonDirector 2016-11-18Sell6,330$105.28-1.15view
HIGGINS JOHN LCEO 2016-09-22Sell3,000$117.34-11.31view
KOZARICH JOHN WDirector 2016-09-07Sell1,000$115-9.5view
KOZARICH JOHN WDirector 2016-09-01Sell1,666$105.4-1.26view
FOEHR MATTHEW WPresident and COO 2016-08-05Sell12,500$122.14-14.79view

Quarterly/Annual Reports about LGND:

News about LGND:

Articles On GuruFocus.com
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 
RS Investment Increases Holdings in Ulta Salon, Noble Energy and Fortune Brands Dec 23 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Ligand Pharmaceuticals - Severe competitive threat to key royalty program and “going concern” ri Jun 19 2014 
5 Hot Stocks to Consider Now Mar 30 2012 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) May 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2009 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
Ligand to Participate in Upcoming Investor Conference Mar 09 2017
New Strong Sell Stocks for March 7th Mar 07 2017
Ligand Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : LGND-US :... Mar 07 2017
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events Mar 06 2017
LIGAND PHARMACEUTICALS INC Financials Mar 03 2017
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events Mar 03 2017
Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: 2016 By the Numbers : March 1, 2017 Mar 01 2017
Ligand Provides Highlights from Today’s Analyst Day Event Feb 28 2017
4:04 pm Ligand Pharma expands its license with Sermonix Pharmaceuticals to include worldwide rights... Feb 28 2017
Ligand Expands License with Sermonix to Include Worldwide Rights for Oral Lasofoxifene Feb 28 2017
6 Stocks on the Move With Unusual Volume Feb 28 2017
LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Feb 28 2017
Sermonix Pharmaceuticals Secures Worldwide Rights to Oral Lasofoxifene From Ligand Pharmaceuticals,... Feb 28 2017
LIGAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Feb 28 2017
Ligand Pharmaceuticals, Inc. :LGND-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27,... Feb 27 2017
Enrollment Completed in Ligand’s Phase 2 Trial of LGD-6972 in Type 2 Diabetes Feb 27 2017
Ligand (LGND) Q4 Earnings Down Y/Y, Revenues Miss Estimates Feb 24 2017
Edited Transcript of LGND earnings conference call or presentation 23-Feb-17 9:30pm GMT Feb 24 2017
Ligand reports 4Q loss Feb 23 2017
Ligand reports 4Q loss Feb 23 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)